Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00741026 · ClinicalTrials.gov registry record · NA
A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00741026 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT00741026, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to examine the acute hormonal and metabolic effects of the drug olanzapine, as well as appetite effects, in healthy volunteers. The hypotheses to be tested are that: (1) Olanzapine rapidly attenuates plasma leptin and (2) rapidly alters glucose tolerance in healthy volunteers. These questions will be answered by having volunteers undergo two glucose tolerance tests in a crossover study design.
Interventions
- DRUG Placebo
- DRUG Olanzapine 10 mg po qhs for 3 days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00741026
The ClinicalTrials.gov registry entry for NCT00741026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00741026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00741026 about?
NCT00741026 is a clinical study titled "A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers". The purpose of this clinical research study is to examine the acute hormonal and metabolic effects of the drug olanzapine, as well as appetite effects, in healthy volunteers. The hypotheses to be tested are that: (1) Olanzapine rapidly attenuates plasma leptin and (2) rapidly alters glucose toleranc...
What is the current status of trial NCT00741026?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00741026?
The interventions under investigation include: Placebo (DRUG), Olanzapine 10 mg po qhs for 3 days (DRUG).
Who is sponsoring clinical trial NCT00741026?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.